Laboratories Nexelis Canada Inc.
Doing business as Pairimmune Part of Nexelis Group Inc.
- UEI
- MBEZLEGWHUN5
- CAGE
- L0MC2
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Nexelis Group Inc.
HK3KXBYJAJR8
-
Parent
Nexelis Group Inc.
HK3KXBYJAJR8
- SAM.gov registration date
- Website
- iqvia.com
- Founded
- 1982
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Monogram Biosciences, Inc. | South San Francisco, CA | 621511 Medical Laboratories |
| Cerba Research Usa, Inc. | New Hyde Park, NY | 621511 Medical Laboratories |
| Prom Health Development Organization | Phnom Penh, Phnom Penh | 923120 Administration of Public Health Programs |
| Qiagen Beverly, LLC | Beverly, MA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Celltrion USA Inc. | Jersey City, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Laboratories Nexelis Canada Inc., doing business as Pairimmune, is a specialty laboratory providing services like assay development, bioanalytical testing, and immunology support for pharmaceutical innovation. Nexelis, a Q² Solutions Company, is registered as a for-profit corporate entity to receive federal awards.
Pairimmune has received several prime contract awards from the Department of Health and Human Services (HHS) to support the federal COVID-19 response. These include a $14.7 million firm-fixed-price definitive contract from the HHS Office of the Assistant Secretary for Preparedness and Response to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials and assay development for emerging variants. Additionally, Pairimmune was awarded a $14.56 million purchase order from the same agency to establish high throughput immunoassay capability and test human serum samples related to the pandemic. Pairimmune also received a $204,000 purchase order from the National Institutes of Health National Institute on Drug Abuse to acquire SARS-CoV-2 pseudoparticles for variant research. None of these HHS contract awards involved set-asides, and Pairimmune served as the prime contractor leveraging its immunology and infectious disease testing expertise.
Quick answers
Is Laboratories Nexelis Canada Inc. registered in SAM.gov?
Laboratories Nexelis Canada Inc.'s SAM.gov registration expired on August 26, 2025.
What is Laboratories Nexelis Canada Inc.'s CAGE code?
Laboratories Nexelis Canada Inc.'s CAGE code is L0MC2, and its Unique Entity ID (UEI) is MBEZLEGWHUN5.
What is Laboratories Nexelis Canada Inc.'s most recent federal award?
Laboratories Nexelis Canada Inc.'s most recent federal contract award is High throughput sars-COV-2 binding antibody immunoassay for testing of clinical samples and variant assessment (75A50122C00013), from Office of the Assistant Secretary for Preparedness and Response, on January 1, 2022.
On GovTribe
See Laboratories Nexelis Canada Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors